Bilcare

₹73.10As of Sun 8 Nov 2026, 12:00 UTC

NSE:BI—

Country India

PE (Fwd) 58.49

TSR 10Y CAGR —

Div yield —

ROE —

Pharmaceutical Preparations

Beta (5Y) —

PE TTM 99.58

TSR TTM —

Mkt cap ₹1.829B

ROIC —

SE Grade™

—

Value

—

Quality

Moat

—

1Y Price

Reference

₹80

—

9.23%

—

FY23

FY24

FY25

FY26

Earnings per share₹

6.39

(14.12)

(0.33)

0.73

219.44%

(320.97%)

97.64%

319.35%

Revenue₹B

9.816

7.472

7.880

7.335

16.21%

(23.88%)

5.47%

(6.92%)

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

7.335

Revenue₹B

—

8.447

9.816

7.472

7.880

7.335

7.545

(3.47%)

(6.92)

Revenue growth%

—

16.21

(23.88)

5.47

(6.92)

2.86

(0.72)

—

32.72

Gross margin%

—

28.52

24.29

32.05

31.58

32.72

32.59

31.58

3.39

Operating margin%

—

2.62

1.93

(0.77)

3.51

3.39

3.37

2.62

0.24

Net margin%

—

(1.49)

1.53

(4.45)

(0.10)

0.24

0.33

(0.10)

99.58

P/E ratio (avg)x

—

69.11

—

100

6.919

EV/EBITx

—

6.769

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

0.73

EPS₹

—

(5.35)

6.39

(14.12)

(0.33)

0.73

1.06

(51.39%)

—

320.57

EPS growth%

—

219.50

(320.93)

97.64

320.57

44.09

158.57

—

Bookvalue per sh₹

—

FCF per share₹

—

Dividend per sh₹

—

Div yield (avg)%

—

Payout ratio%

—

23.55

Shares (diluted)M

—

23.55

◌23.55

—

Buyback yield%

—

◌—

—

D/E ratiox

—

1.721

Enterprise value₹B

—

1.721

—

100

—

LT debt₹M

—

100

Peers (US$18.82M)

Cap (US$)

Oxygenta Pharmaceutica…

19.08M

—

Coral Laboratories…

18.95M

9.266x

Kerala Ayurveda Limited

18.40M

—

Pharmsville Co., Ltd.

19.32M

8.765x

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

0.372

0.352

Own earn%

—

Sh yield%

—

Owners

Insiders/Inst%

48.08

—

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

2/5

Revenue growth years

2/4

EPS growth years

3/4

Dividend streakyrs

Op margin range%

−1–4

$1 testx

—

Incr. ROIC%

—

Bilcare Limited provides pharmaceutical packaging research solutions in India and internationally. The company offers aluminum foils, polymer films, and anti-counterfeiting packaging solutions for solid dosage pharmaceutical products and other applications; and blister films and foils, lidding foils, CR foils, and laminates.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹7.335B

(3.47%)

1.00×

Cost of revenue

₹4.935B

(4.92%)

0.94×

Operating expenses

₹2.152B

(0.42%)

1.13×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

Return on capital

n/m

Spread over hurdle

n/m